BioGaia AB Financials
| BIOG-B Stock | SEK 121.40 1.00 0.83% |
BioGaia |
Understanding current and past BioGaia AB Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BioGaia AB's financial statements are interrelated, with each one affecting the others. For example, an increase in BioGaia AB's assets may result in an increase in income on the income statement.
Please note, the presentation of BioGaia AB's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BioGaia AB's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of BioGaia AB's management manipulating its earnings.
BioGaia AB Stock Summary
BioGaia AB competes with Biotage AB, CellaVision, Sectra AB, Elekta AB, and Probi AB. BioGaia AB develops, markets, and sells probiotic products with documented health benefits worldwide. BioGaia AB was founded in 1990 and is headquartered in Stockholm, Sweden. BioGaia AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 144 people.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0017769995 |
| Business Address | Kungsbroplan 3, Stockholm, |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.biogaia.com |
| Phone | 46 8 55 52 93 00 |
| Currency | SEK - Swedish Kronor |
You should never invest in BioGaia AB without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of BioGaia Stock, because this is throwing your money away. Analyzing the key information contained in BioGaia AB's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
BioGaia AB Key Financial Ratios
BioGaia AB's financial ratios allow both analysts and investors to convert raw data from BioGaia AB's financial statements into concise, actionable information that can be used to evaluate the performance of BioGaia AB over time and compare it to other companies across industries.BioGaia Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioGaia AB's current stock value. Our valuation model uses many indicators to compare BioGaia AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioGaia AB competition to find correlations between indicators driving BioGaia AB's intrinsic value. More Info.BioGaia AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.54 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for BioGaia AB is roughly 1.86 . Comparative valuation analysis is a catch-all model that can be used if you cannot value BioGaia AB by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioGaia AB's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.BioGaia AB Systematic Risk
BioGaia AB's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. BioGaia AB volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on BioGaia AB correlated with the market. If Beta is less than 0 BioGaia AB generally moves in the opposite direction as compared to the market. If BioGaia AB Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one BioGaia AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of BioGaia AB is generally in the same direction as the market. If Beta > 1 BioGaia AB moves generally in the same direction as, but more than the movement of the benchmark.
BioGaia AB February 1, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of BioGaia AB help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BioGaia AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of BioGaia AB based on widely used predictive technical indicators. In general, we focus on analyzing BioGaia Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BioGaia AB's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.36 | |||
| Information Ratio | 0.1744 | |||
| Maximum Drawdown | 7.76 | |||
| Value At Risk | (2.33) | |||
| Potential Upside | 2.67 |
Complementary Tools for BioGaia Stock analysis
When running BioGaia AB's price analysis, check to measure BioGaia AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioGaia AB is operating at the current time. Most of BioGaia AB's value examination focuses on studying past and present price action to predict the probability of BioGaia AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioGaia AB's price. Additionally, you may evaluate how the addition of BioGaia AB to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Stocks Directory Find actively traded stocks across global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |